Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis
- PMID: 26829052
- DOI: 10.1038/onc.2015.515
Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis
Abstract
Protein synthesis activity is abnormally enhanced in cancer cells to support their uncontrolled growth. However, this process needs to be tightly restricted under metabolic stress-a condition often found within the tumor microenvironment-to preserve cell viability. mTORC1 is critical to link protein synthesis activity to nutrient and oxygen levels, in part by controlling the 4E-BP1-eIF4E axis. Whereas mTORC1 and eIF4E are known pro-tumorigenic factors, whose expression or activity is increased in numerous cancers, the role of 4E-BP1 in cancer is not yet definitive. On the one hand, 4E-BP1 has tumor suppressor activity by inhibiting eIF4E and, thus, blocking mRNA translation and proliferation. This is corroborated by elevated levels of phosphorylated and hence inactive 4E-BP1, which are detected in various cancers. On the other hand, 4E-BP1 has pro-tumorigenic functions as it promotes tumor adaptation to metabolic and genotoxic stress by selectively enhancing or preventing the translation of specific transcripts. Here we describe the molecular and cellular functions of 4E-BP1 and highlight the distinct roles of 4E-BP1 in cancer depending on the microenvironmental context of the tumor.
Similar articles
-
The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.Int J Oncol. 2011 Nov;39(5):1337-45. doi: 10.3892/ijo.2011.1118. Epub 2011 Jul 8. Int J Oncol. 2011. PMID: 21750861
-
Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.Mol Med Rep. 2013 Feb;7(2):537-42. doi: 10.3892/mmr.2012.1208. Epub 2012 Nov 28. Mol Med Rep. 2013. PMID: 23229050
-
Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.Int J Clin Exp Pathol. 2015 Jan 1;8(1):404-13. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755728 Free PMC article.
-
4E-BP1, a multifactor regulated multifunctional protein.Cell Cycle. 2016;15(6):781-6. doi: 10.1080/15384101.2016.1151581. Cell Cycle. 2016. PMID: 26901143 Free PMC article. Review.
-
Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.Eur J Cell Biol. 2017 Jun;96(4):325-336. doi: 10.1016/j.ejcb.2017.03.013. Epub 2017 Apr 8. Eur J Cell Biol. 2017. PMID: 28427795 Review.
Cited by
-
RNA binding protein-directed control of leukemic stem cell evolution and function.Hemasphere. 2024 Aug 22;8(8):e116. doi: 10.1002/hem3.116. eCollection 2024 Aug. Hemasphere. 2024. PMID: 39175825 Free PMC article. Review.
-
mTORC1 mediates the expansion of hematopoietic stem and progenitor cells through ribosome biogenesis protein Urb2 in zebrafish.Stem Cell Reports. 2024 Sep 10;19(9):1277-1288. doi: 10.1016/j.stemcr.2024.07.011. Epub 2024 Aug 22. Stem Cell Reports. 2024. PMID: 39178846 Free PMC article.
-
LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway.Aging (Albany NY). 2020 Sep 5;12(16):16142-16154. doi: 10.18632/aging.103589. Aging (Albany NY). 2020. PMID: 32628130 Free PMC article.
-
A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration.Front Genet. 2022 Mar 11;13:845751. doi: 10.3389/fgene.2022.845751. eCollection 2022. Front Genet. 2022. PMID: 35360872 Free PMC article.
-
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.Front Immunol. 2022 Feb 18;12:774103. doi: 10.3389/fimmu.2021.774103. eCollection 2021. Front Immunol. 2022. PMID: 35250965 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials